Zepzelca™ (lurbinectedin) – New orphan drug approval
June 15, 2020 - Jazz Pharmaceuticals and PharmaMar announced the FDA approval of Zepzelca (lurbinectedin), for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.
Top